Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees

Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi.

Investors Business Daily

Risk of COVID death or hospitalisation 88 per cent lower for those previously infected, study finds

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

ABC News

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna won’t raise price on COVID vaccine after pressure

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

Tribune News Service

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

Reuters

Moderna Stock Getting Closer To Key Technical Benchmark

A Relative Strength Rating upgrade for Moderna shows improving technical performance. Will it continue?

Investors Business Daily

Q&A: Why Bernie Sanders says his ‘Medicare for All’ dream must wait

After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Haven't had COVID or a vaccine dose in the past six months? Consider getting a booster

Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.

The Conversation

Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask

“Patients need to advocate for themselves."

Fortune

End of public health emergency causes cascade of changes

WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

Tribune News Service

End of public health emergency causes cascade of changes - Roll Call

The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.

Roll Call

Health department reviewing fifth COVID-19 vaccine. But what if you have missed a dose?

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.

ABC News

‘Lots of tears’ when vaccine was produced, scientist says while receiving OBE

Dr Ivarsson recalled the emotional day when the results from Moderna’s vaccine trials were announced.

The Independent UK

Moderna Scores A Win In RSV — But Its Shares Don't Reflect That

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

Carol Vorderman targets Rishi Sunak and Michelle Mone on Twitter after This Morning rant

TV personality continues to target Prime Minister and baroness after prompting huge response with her TV allegations against the pair

Investors Business Daily

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip

Novavax plans to update its Covid vaccine for new variants, and NVAX stock outperformed its vaccine stock rivals.

Daily Mirror

Carol Vorderman demands Rishi Sunak be investigated for insider trading in attack on Tories

Carol Vorderman has demanded Rishi Sunak should be investigated for insider trading as she launched a blistering attack on the Tories today whilst appearing on ITV's This Morning

The Independent UK

FDA's advisers back plan to simplify COVID-19 vaccinations

The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

Updated COVID vaccines prevented illness from latest variants -CDC

The updated COVID-19 boosters from Pfizer Inc/BioNTech SE and Moderna helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines perform against these fast-spreading strains, U.S. officials said on Wednesday.

Sports Illustrated

What on Earth Is Aaron Rodgers Talking About?

The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.

Los Angeles Times

Michael Hiltzik: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

Stéphane Bancel, the chief executive of drug company Moderna, could barely restrain his pride in issuing his annual letter to shareholders on Jan. 3.

Tribune News Service

FDA lays out annual COVID shot plan similar to flu

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

Inverse

New mRNA cancer vaccine has a key difference from most jabs

The experimental Moderna melanoma vaccine can't prevent melanoma, but it can be used to treat the cancer.

The Guardian - UK

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer

The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumours

Investors Business Daily

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Department of Justice

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.